In this ODwire.org webinar, Melissa Barnett, OD and Susan Resnick, OD help us learn more about ptosis, including causes, diagnosis, treatment landscape, impact on patients, and opportunity for your practice.
Jason Bacharach, MD, introduces the first and only FDA-approved pharmacologic treatment for acquired blepharoptosis, RVL-1201 (oxymetazoline hydrochloride ophthalmic solution), 0.1%, including its mechanism of action and clinical data.
Thu, Jul 23, 2020 8pm ET / 5pm PT
Join our special guest, Dr. Katie Spear, as she discusses how PRECISION1® daily disposable contact lenses have helped her practice welcome patients into contact lenses for the first time and reduce contact lens dropout in patients being refit into new contact lenses.
PRECISION1® contact lenses, with SmartSurface® Technology, are the latest innovation from Alcon. PRECISION1® contact lenses are born from the Water Gradient Technology of DAILIES TOTAL1® but offered at a mainstream price. They can provide patients with precise vision, dependable comfort, and ease of handling which are the core reasons for contact lens dropout.
We hope you can join us to learn how PRECISION1® contact lenses can benefit your patients and your practice!
